Literature DB >> 27522549

Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.

Fabio Conti1, Ranka Vukotic1, Francesco Giuseppe Foschi2, Marco Domenicali1, Pierluigi Giacomoni2, Sara Savini2, Arianna Lanzi2, Anna Chiara Dall'Aglio2, Gaia Saini2, Marianna Matroroberto1, Mauro Bernardi1, Giuseppe Francesco Stefanini2, Pietro Andreone3.   

Abstract

BACKGROUND: Few studies have been performed to explore parameters that influence liver stiffness measurement (LSM) using transient elastography in general population. AIM: To explore factors influencing LSM in healthy and in subjects with non-alcoholic fatty liver disease (NAFLD).
METHODS: LSM was performed in a well-characterized cohort of subjects aged between 30 and 63 years. After exclusion of any causes of liver disease, the healthy cohort was defined and was compared with participants with NAFLD. The 95th percentile value of LSM in healthy was used as a cutoff suggesting relevant fibrosis.
RESULTS: Among 780 subjects evaluated, 331 were defined as healthy. The median value was 4.4kPa (3.7-5.2) and the 95th percentile was 6.8kPa. LSM was not influenced by gender, age, anthropometrics and biochemical parameters. Only insulin resistance was independently associated with increasing of LSM. In the cohort of 157 subjects with NAFLD, LSM was higher than in healthy (5.6±1.9 vs 4.6±1.3kPa; p<0.001). On multivariate analysis, the degree of steatosis was independently associated with increasing of LSM in NAFLD cohort (β=0.271; 95% CI=0.026-0.095; p<0.001). Participants with diabetes and/or severe steatosis had the highest probabilities of relevant fibrosis.
CONCLUSIONS: LSM varies between 3.7 and 5.2kPa in healthy Caucasians and is influenced only by insulin resistance. In NAFLD, severe steatosis and diabetes are factors influencing LSM.
Copyright © 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibroscan; Insulin resistance; NAFLD; Normal value

Mesh:

Year:  2016        PMID: 27522549     DOI: 10.1016/j.dld.2016.07.020

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

Review 1.  Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).

Authors:  Ma Ai Thanda Han; Rola Saouaf; Walid Ayoub; Tsuyoshi Todo; Edward Mena; Mazen Noureddin
Journal:  Expert Rev Clin Pharmacol       Date:  2017-03-09       Impact factor: 5.045

2.  Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans.

Authors:  Gordon P Watt; Isela De La Cerda; Jen-Jung Pan; Michael B Fallon; Laura Beretta; Rohit Loomba; Miryoung Lee; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Hepatol Commun       Date:  2020-10-31

3.  Laboratory Tests, Liver Vessels Color Doppler Sonography, and FibroScan Findings in Patients with Nonalcoholic Fatty Liver Disease: An Observation Study.

Authors:  Ahmad Alizadeh; Fariborz Mansour-Ghanaei; Ava Roozdar; Farahnaz Joukar; Masood Sepehrimanesh; Seyedeh Amineh Hojati; Alireza Mansour-Ghanaei
Journal:  J Clin Imaging Sci       Date:  2018-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.